OptiMedica Corp. is a Silicon Valley-based global ophthalmic device company dedicated to developing performance-driven technologies that improve patient outcomes. Now exclusively focused in the cataract therapeutic area, the company previously developed and commercialized the PASCAL Method of retinal photocoagulation, which was acquired by Topcon Corp. in August 2010. Founded in 2004, OptiMedica is headquartered in Santa Clara, Calif., with international offices in Singapore. The company is funded by Kleiner Perkins Caufield & Byers, Alloy Ventures, DAG Ventures, BlackRock Private Equity Partners and Bio*One Capital. For more information, please visit www.optimedica.com.
View Top Employees from OptiMedicaWebsite | https://www.optimedica.com |
Revenue | $8 million |
Funding | $68.6 million |
Employees | 41 (30 on RocketReach) |
Founded | 2004 |
Phone | (408) 850-8600 |
Technologies |
HTML,
Microsoft Outlook,
Amazon s3
+12 more
(view full list)
|
Industry | Retail, Medical Devices, Biotechnology, Surgical Devices, Laser Cataract Surgery, Science and Engineering, Ophthalmology, Health Care, Medical Device |
Web Rank | 22 Million |
SIC | SIC Code 38 Companies, SIC Code 385 Companies |
NAICS | NAICS Code 339 Companies, NAICS Code 33 Companies |
Looking for a particular OptiMedica employee's phone or email?
The OptiMedica annual revenue was $8 million in 2024.
Linda Raggi is the Director Finance of OptiMedica.
30 people are employed at OptiMedica.
OptiMedica is based in Koliba, Bratislava.
The NAICS codes for OptiMedica are [339, 33].
The SIC codes for OptiMedica are [38, 385].